XORTX Therapeutics Inc.(XRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

XRTX XORTX Therapeutics Inc.

盘前交易 02-06 08:31:56 EST

0.4032

-0.0868

-17.71%

盘前0.3819

-0.0213-5.28%

08:31 EST

最高0.5010	最低0.4032	成交量253.22万
今开0.4860	昨收0.4900	日振幅19.96%
总市值280.72万	流通市值252.14万	总股本696.22万
成交额120.79万	换手率40.49%	流通股本625.34万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"XRTX","market":"US","secType":"STK","nameCN":"XORTX Therapeutics Inc.","latestPrice":0.4032,"timestamp":1770325200000,"preClose":0.49,"halted":0,"volume":2532163,"hourTrading":{"tag":"盘前","latestPrice":0.3819,"preClose":0.4032,"latestTime":"08:31 EST","volume":13870,"amount":5252.7817658,"timestamp":1770384712150,"change":-0.0213,"changeRate":-0.052827,"amplitude":0.104415},"delay":0,"changeRate":-0.17714285714285713,"floatShares":6253400,"shares":6962218,"eps":-0.496086,"marketStatus":"盘前交易","change":-0.0868,"latestTime":"02-06 08:31:56 EST","open":0.486,"high":0.501,"low":0.4032,"amount":1207882.7720406,"amplitude":0.199592,"askPrice":0.4146,"askSize":100,"bidPrice":0.3208,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-0.496086,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770388200000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":0.4032,"preHourTrading":{"tag":"盘前","latestPrice":0.3819,"preClose":0.4032,"latestTime":"08:31 EST","volume":13870,"amount":5252.7817658,"timestamp":1770384712150,"change":-0.0213,"changeRate":-0.052827,"amplitude":0.104415},"postHourTrading":{"tag":"盘后","latestPrice":0.3367,"preClose":0.4032,"latestTime":"19:59 EST","volume":69380,"amount":25798.5448,"timestamp":1770339560891,"change":-0.0665,"changeRate":-0.164931,"amplitude":0.265625},"volumeRatio":4.287348665294137},"requestUrl":"/m/hq/s/XRTX","defaultTab":"news","newsList":[{"id":"2587071734","title":"Xortx Therapeutics Inc.盘中异动 快速拉升5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2587071734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587071734?lang=zh_cn&edition=full","pubTime":"2025-11-28 23:10","pubTimestamp":1764342650,"startTime":"0","endTime":"0","summary":"北京时间2025年11月28日23时10分，Xortx Therapeutics Inc.股票出现异动，股价大幅拉升5.41%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112823105097850b9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112823105097850b9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","BK4539","XRTX"],"gpt_icon":0},{"id":"2586472305","title":"Xortx Therapeutics Inc.盘中异动 早盘大幅上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586472305","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586472305?lang=zh_cn&edition=full","pubTime":"2025-11-25 23:22","pubTimestamp":1764084131,"startTime":"0","endTime":"0","summary":"北京时间2025年11月25日23时22分，Xortx Therapeutics Inc.股票出现波动，股价急速上涨5.03%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125232211a710eec5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125232211a710eec5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","XRTX","BK4139","BK4007"],"gpt_icon":0},{"id":"2517654691","title":"Xortx Therapeutics Inc.盘中异动 快速上涨5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517654691","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517654691?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:31","pubTimestamp":1741271508,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时31分，Xortx Therapeutics Inc.股票出现波动，股价快速上涨5.94%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.63%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223148a2628fad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223148a2628fad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","XRTX","BK4007"],"gpt_icon":0},{"id":"2516637978","title":"Xortx Therapeutics Inc.盘中异动 急速下挫6.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516637978","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516637978?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:58","pubTimestamp":1741013936,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时58分，Xortx Therapeutics Inc.股票出现波动，股价急速跳水6.92%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032258569637b3e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032258569637b3e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","XRTX","BK4139"],"gpt_icon":0},{"id":"2514378109","title":"Xortx Therapeutics Inc.股价重挫10.38% 市值跌41.5万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514378109","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514378109?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:30","pubTimestamp":1740753030,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时30分，Xortx Therapeutics Inc.股票出现异动，股价快速下跌10.38%。截至发稿，该股报0.950美元/股，成交量1.2555万股，换手率0.39%，振幅0.00%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Virpax Pharmaceuticals, Inc.、Bioxcel Therapeutics, Inc.、Ensysce Biosciences, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Virpax Pharmaceuticals, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为480.20%、239.09%、53.23%，振幅较大的相关个股有Tiziana Life Sciences Ltd、Aardvark Therapeutics, Inc.、Lexeo Therapeutics, Inc.，振幅分别为8.85%、6.22%、4.85%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223030963418f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223030963418f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","XRTX","LENZ"],"gpt_icon":0},{"id":"2514133567","title":"Xortx Therapeutics Inc.盘中异动 下午盘股价大涨8.04%报0.900美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514133567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514133567?lang=zh_cn&edition=full","pubTime":"2025-02-28 02:04","pubTimestamp":1740679441,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日02时04分，Xortx Therapeutics Inc.股票出现异动，股价急速上涨8.04%。截至发稿，该股报0.900美元/股，成交量3.5557万股，换手率1.10%，振幅9.60%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.42%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228020401abdf9f33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228020401abdf9f33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","XRTX","BK4007","BK4139"],"gpt_icon":0},{"id":"2514041856","title":"Xortx Therapeutics Inc.盘中异动 早盘股价大涨5.55%报0.900美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514041856","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514041856?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:34","pubTimestamp":1740580494,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时34分，Xortx Therapeutics Inc.股票出现异动，股价急速上涨5.55%。截至发稿，该股报0.900美元/股，成交量122股，换手率0.00%，振幅0.00%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262234549893ab68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262234549893ab68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","XRTX","BK4007"],"gpt_icon":0},{"id":"2514090229","title":"Xortx Therapeutics Inc.盘中异动 早盘股价大涨6.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514090229?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:31","pubTimestamp":1740493884,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时31分，Xortx Therapeutics Inc.股票出现波动，股价大幅拉升6.40%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Organovo Holdings, Inc.、Moleculin Biotech, Inc.、Silexion Therapeutics Corp涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为746.68%、510.41%、459.93%，振幅较大的相关个股有Organovo Holdings, Inc.、Igm Biosciences, Inc.、Pluri Inc.，振幅分别为8.13%、7.46%、7.15%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223124a2538678&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223124a2538678&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","XRTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2513727156","title":"Xortx Therapeutics Inc.盘中异动 早盘急速上涨5.50%报0.865美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727156","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513727156?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:38","pubTimestamp":1740407927,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时38分，Xortx Therapeutics Inc.股票出现异动，股价大幅上涨5.50%。截至发稿，该股报0.865美元/股，成交量7479股，换手率0.23%，振幅2.09%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223848962e9a6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223848962e9a6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","XRTX","BK4139","BK4007"],"gpt_icon":0},{"id":"2513294492","title":"Xortx Therapeutics Inc.盘中异动 早盘股价大跌7.88%报0.871美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513294492","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513294492?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:48","pubTimestamp":1740152913,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日23时48分，Xortx Therapeutics Inc.股票出现异动，股价快速下跌7.88%。截至发稿，该股报0.871美元/股，成交量2.2839万股，换手率0.71%，振幅5.29%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221234834abd7c0e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221234834abd7c0e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","XRTX","BK4007"],"gpt_icon":0},{"id":"2511561353","title":"Xortx Therapeutics Inc.盘中异动 股价大跌5.20%报0.910美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511561353","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511561353?lang=zh_cn&edition=full","pubTime":"2025-02-15 01:31","pubTimestamp":1739554275,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日01时31分，Xortx Therapeutics Inc.股票出现异动，股价快速下跌5.20%。截至发稿，该股报0.910美元/股，成交量1.2959万股，换手率0.40%，振幅5.19%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.62%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215013116a24627cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215013116a24627cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XRTX","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2509272797","title":"Xortx Therapeutics Inc.盘中异动 快速上涨6.74%报0.950美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509272797","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509272797?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:50","pubTimestamp":1738853402,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时50分，Xortx Therapeutics Inc.股票出现波动，股价急速拉升6.74%。截至发稿，该股报0.950美元/股，成交量1570股，换手率0.05%，振幅6.74%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206225003abc4d95f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206225003abc4d95f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","XRTX"],"gpt_icon":0},{"id":"2508457719","title":"Xortx Therapeutics Inc.盘中异动 股价大涨6.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508457719","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508457719?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:36","pubTimestamp":1738679804,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时36分，Xortx Therapeutics Inc.股票出现波动，股价大幅上涨6.04%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223644a23929f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223644a23929f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XRTX","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2508403231","title":"Xortx Therapeutics Inc.盘中异动 急速下挫5.26%报0.900美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508403231","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508403231?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:51","pubTimestamp":1738597861,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时51分，Xortx Therapeutics Inc.股票出现波动，股价急速下跌5.26%。截至发稿，该股报0.900美元/股，成交量1.538万股，换手率0.48%，振幅5.26%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.67%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203235101abc11890&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203235101abc11890&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XRTX","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2506858128","title":"Xortx Therapeutics Inc.盘中异动 股价大涨9.89%报1.000美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506858128","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506858128?lang=zh_cn&edition=full","pubTime":"2025-01-28 04:00","pubTimestamp":1738008003,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日04时00分，Xortx Therapeutics Inc.股票出现波动，股价大幅上涨9.89%。截至发稿，该股报1.000美元/股，成交量4.2585万股，换手率1.32%，振幅10.99%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.72%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280400039874df91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280400039874df91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","XRTX"],"gpt_icon":0},{"id":"2503150649","title":"Xortx Therapeutics Inc.盘中异动 急速下跌6.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503150649","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503150649?lang=zh_cn&edition=full","pubTime":"2025-01-16 22:49","pubTimestamp":1737038972,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日22时49分，Xortx Therapeutics Inc.股票出现异动，股价急速跳水6.36%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.67%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116224932a22463db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116224932a22463db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XRTX","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2503664788","title":"Xortx Therapeutics Inc.股价重挫29.92% 市值跌85.84万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503664788","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503664788?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:33","pubTimestamp":1736951605,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时33分，Xortx Therapeutics Inc.股票出现异动，股价大幅下挫29.92%。截至发稿，该股报0.890美元/股，成交量29.934万股，换手率9.29%，振幅3.06%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Exicure, Inc.、Allovir, Inc.、Cabaletta Bio, Inc.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为185.53%、57.39%、35.56%，振幅较大的相关个股有Onconetix, Inc.、Eterna Therapeutics Inc.、Klotho Neurosciences, Inc.，振幅分别为14.29%、12.79%、12.00%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223325ababf2f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223325ababf2f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","XRTX","BK4007"],"gpt_icon":0},{"id":"2502389992","title":"Xortx Therapeutics Inc.盘中异动 早盘股价大跌6.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502389992","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502389992?lang=zh_cn&edition=full","pubTime":"2025-01-11 00:07","pubTimestamp":1736525277,"startTime":"0","endTime":"0","summary":"北京时间2025年01月11日00时07分，Xortx Therapeutics Inc.股票出现异动，股价大幅跳水6.92%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.52%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111000757aba619bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111000757aba619bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XRTX","BK4007","LENZ"],"gpt_icon":0},{"id":"2502037705","title":"Xortx Therapeutics Inc.盘中异动 快速拉升9.24%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502037705","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502037705?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:31","pubTimestamp":1736346672,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时31分，Xortx Therapeutics Inc.股票出现异动，股价大幅上涨9.24%。截至发稿，该股报1.30美元/股，成交量5052股，换手率0.16%，振幅0.00%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108223112aba34a79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108223112aba34a79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","XRTX"],"gpt_icon":0},{"id":"2501824787","title":"Xortx Therapeutics Inc.盘中异动 股价大跌9.16%报1.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501824787","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501824787?lang=zh_cn&edition=full","pubTime":"2025-01-07 22:55","pubTimestamp":1736261723,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日22时55分，Xortx Therapeutics Inc.股票出现异动，股价急速跳水9.16%。截至发稿，该股报1.19美元/股，成交量2906股，换手率0.09%，振幅0.76%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.32%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107225523a218ece1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107225523a218ece1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XRTX","BK4007","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xortx.com","stockEarnings":[{"period":"1week","weight":-0.1771},{"period":"1month","weight":-0.328},{"period":"3month","weight":-0.2775},{"period":"6month","weight":-0.4928},{"period":"1year","weight":-0.547},{"period":"ytd","weight":-0.2826}],"compareEarnings":[{"period":"1week","weight":-0.0237},{"period":"1month","weight":-0.0205},{"period":"3month","weight":0.0099},{"period":"6month","weight":0.0635},{"period":"1year","weight":0.1215},{"period":"ytd","weight":-0.0063}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"XORTX Therapeutics Inc.于2012年8月24日根据加拿大艾伯塔省的法律注册成立，名称为ReVasCor Inc.在2018年1月10日，公司名称更改为“XORTX Therapeutics Inc.”。该公司是一家临床阶段的生物技术公司，专注于识别、开发和商业化治疗由异常嘌呤和尿酸代谢调节的进行性肾脏疾病的疗法，这些肾脏适应症包括ADPKD、冠状病毒COVID-19感染引起的AKI和T2DN。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.151697},{"month":2,"riseRate":0.4,"avgChangeRate":0.005853},{"month":3,"riseRate":0.5,"avgChangeRate":0.09248},{"month":4,"riseRate":0.5,"avgChangeRate":-0.051078},{"month":5,"riseRate":0.5,"avgChangeRate":-0.010505},{"month":6,"riseRate":0.25,"avgChangeRate":-0.056347},{"month":7,"riseRate":0.25,"avgChangeRate":-0.068974},{"month":8,"riseRate":0.75,"avgChangeRate":0.072811},{"month":9,"riseRate":0.25,"avgChangeRate":-0.105232},{"month":10,"riseRate":0,"avgChangeRate":-0.2951},{"month":11,"riseRate":0.4,"avgChangeRate":-0.057012},{"month":12,"riseRate":0,"avgChangeRate":-0.097703}],"exchange":"NASDAQ","name":"XORTX Therapeutics Inc.","nameEN":"XORTX Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"XORTX Therapeutics Inc.(XRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供XORTX Therapeutics Inc.(XRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"XORTX Therapeutics Inc.,XRTX,XORTX Therapeutics Inc.股票,XORTX Therapeutics Inc.股票老虎,XORTX Therapeutics Inc.股票老虎国际,XORTX Therapeutics Inc.行情,XORTX Therapeutics Inc.股票行情,XORTX Therapeutics Inc.股价,XORTX Therapeutics Inc.股市,XORTX Therapeutics Inc.股票价格,XORTX Therapeutics Inc.股票交易,XORTX Therapeutics Inc.股票购买,XORTX Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"XORTX Therapeutics Inc.(XRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供XORTX Therapeutics Inc.(XRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}